- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 48.35M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $167.16M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $137.04M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $898.77M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $980.45M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.16B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.22B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 48.97M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $0 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $124.48M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $203.99M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $168.77M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.48 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.50 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $11.25M |
| Net Income | Q1 2025 · Mar 31, 2024 | $23.6M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $30.56M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $66.6M |